GEN Exclusives

More »

The Lists

More »
Jul 29, 2013

Top 15 Pharma Companies of 2013

We've given last year's Top 10 Pharma Firms list an update.

Top 15 Pharma Companies of 2013

These 15 pharmaceutical companies are ranked by their market capitalization for the latest date that they furnished a figure for their numbers of outstanding shares and a year-ago figure for the same.

  • Last year, we gave you the top 10 pharma firms; this year, we turn the volume up to 15. Following is a list of 15 pharmaceutical companies, ranked by their market capitalization for the latest date that they furnished a figure for their numbers of outstanding shares and a year-ago figure for the same. 

    Pharmas, as with the biotechs listed in this space last week, benefited from the stock market surge that lifted share prices by mostly double-digit percentages over the past year. However, none of the 15 top pharma companies listed here had been able to double their market cap year-over-year; by contrast, five biotechs saw their market cap more than double over a 12-month period. Investors rewarded pharmas that performed well, though not as handsomely as biotechs that delivered.

    Another factor in the lower market cap increases of pharmas compared with biotechs was the fact several of the companies were in the middle of restructuring efforts announced in earlier years, mostly related to loss of patent exclusivity on older blockbuster drugs. As reflected by GEN’s recent list of Top 15 Job-Cutting Companies of 2013 (So Far), pharmas carried out more job-cutting in the first half of 2013 compared with 2012.

    The past year also saw some flux among the companies listed. Of this year’s top 15 (the 2012 GEN List of top pharmas included only 10 companies), two pharmas climbed up the list (Novartis and Sanofi); four slipped a notch or more (Roche, Merck & Co., GlaxoSmithKline, and AstraZeneca); three companies were ranked the same as last year; five were ranked for the first time (Bayer, Eli Lilly, Takeda, Astellas, and Daiichi Sankyo); and the remaining company (AbbVie) didn’t exist last year, rendering comparisons to 2012 moot.

  • #15. Daiichi Sankyo

    2013 Market Cap: $12.876 billion (3/31: 704 million shares * price ¥1,815 on 3/29)1,2,3

    2012 Market Cap: $10.701 billion (3/31: 704 million shares * price ¥1,508 on 3/30)1,2,3

    % Change: 20.3%

    Position on 2012 List: Not ranked

  • #14. Astellas

    2013 Market Cap: $23.888 billion (3/31: 467.965 million shares * price ¥5,060 on 3/29)1,2,3

    2012 Market Cap: $16.050 billion (3/31: 467.965 million shares * price ¥3,400 on 3/30)1,2,3

    % Change: 48.8%

    Position on 2012 List: Not ranked

  • #13. Takeda

    2013 Market Cap: $40.056 billion (3/31: 789.666 million shares * price ¥5,030 on 3/29)1,2,3

    2012 Market Cap: $29.027 billion (3/31: 789.666 million shares * price ¥3,645 on 3/30)1,2,3

    % Change: 38.0%

    Position on 2012 List: Not ranked

  • #12. AstraZeneca

    2013 Market Cap: $62.475 billion (3/31: 1.250 billion shares * price $49.98 on 3/28)2

    2012 Market Cap: $56.680 billion (3/31: 1.274 billion shares * price $44.49 on 3/30)2

    % Change: 10.2%

    Position on 2012 List: #10

  • #11. Eli Lilly

    2013 Market Cap: $64.687 billion (4/20: 1,126,561,464 shares * price $57.42 on 4/19)4

    2012 Market Cap: $46.312 billion (4/20: 1,160,415,307 shares * price $39.91)

    % Change: 39.7%

    Position on 2012 List: Not ranked

  • #10. AbbVie

    2013 Market Cap: $64.584 billion (3/31: 1,583,729,114 shares * price $40.78 on 3/28)2

    2012 Market Cap: N/A5

    % Change: N/A5

    Position on 2012 List: N/A5

  • #9. Bristol-Myers Squibb

    2013 Market Cap: $67.657 billion (3/31: 1,642,551,939 shares * price $41.19 on 3/28)2

    2012 Market Cap: $57.007 billion (3/31: 1,689,084,439 shares * price $33.75 on 3/30)2

    % Change: 18.7%

    Position on 2012 List: #9


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?